Ulixacaltamide

Name: Ulixacaltamide in Essential tremor: Average sales price and wholesale acquisition cost
Published: 2026-09-14T15:39:06-04:00

Essential tremor

Manufacturer: Praxis Precision Medicines
Regulatory submission: NDA submitted by February 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information

Average sales price and wholesale acquisition cost

1 evidence topic · 1 source

Manufacturer pricing discussion without a disclosed final price

“We talked about a little bit over maybe $50,000 to $100,000 per year.” (opens the source at this quote in a new tab)
“we're not going to disclose the price specifically” (opens the source at this quote in a new tab)

Marketed-product average sales price and wholesale acquisition cost

Not applicable.